Home LiteratureArticle Details
PMID: 8466274 Published · ppublish English Journal Article Review

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

Archives of disease in childhood ·Vol. 68 ·No. 3 Spec No ·1993-03-00 ·Pages 330-6

Ng PC

Abstract

暂无摘要

MeSH Terms
Bronchopulmonary Dysplasia/drug therapy Dexamethasone/adverse effects,therapeutic use Drug Administration Schedule Humans Infant, Newborn Infant, Premature
Chemicals
Dexamethasone
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Ng P C
Academic Department of Child Health, St Bartholomew's Hospital Medical College, London.
References (33)
33 references, click to expand
  1. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia.
    Arch Dis Child. 1989 Dec;64(12):1721-6 PMID: 2624478
  2. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.
    J Pediatr. 1990 Aug;117(2 Pt 1):273-82 PMID: 2199642
  3. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Pediatrics. 1990 Nov;86(5):722-7 PMID: 2235226
  4. Bronchopulmonary dysplasia: then and now.
    Arch Dis Child. 1990 Oct;65(10 Spec No):1076-81 PMID: 2241231
  5. Renal calcification after dexamethasone in infants with bronchopulmonary dysplasia.
    Lancet. 1991 Mar 9;337(8741):626 PMID: 1671989
  6. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
    Arch Dis Child. 1991 Oct;66(10 Spec No):1164-6 PMID: 1750771
  7. Catabolic effect of dexamethasone in the preterm baby.
    Arch Dis Child. 1992 Jan;67(1 Spec No):1-4 PMID: 1482427
  8. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.
    Thorax. 1992 Jan;47(1):44-7 PMID: 1539144
  9. Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia.
    Arch Dis Child. 1992 Oct;67(10 Spec No):1193-5 PMID: 1444557
  10. Some physiological, biochemical, and behavioral consequences of neonatal hormone administration: cortisol and thyroxine.
    Gen Comp Endocrinol. 1968 Apr;10(2):214-28 PMID: 5653481
  11. Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids.
    Am Rev Respir Dis. 1970 Sep;102(3):459-61 PMID: 5450911
  12. Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid.
    Surg Gynecol Obstet. 1972 Apr;134(4):675-81 PMID: 4552525
  13. Effects of methylprednisolone on pulmonary microcirculation.
    Surg Gynecol Obstet. 1974 Jul;139(1):1-5 PMID: 4834270
  14. Influence of corticosteroid on recovery from oxygen toxicity.
    Am Rev Respir Dis. 1974 Nov;110(5):566-71 PMID: 4429252
  15. DNA, ganglioside and sulfatide in brains of rats given corticosterone in infancy, with an estimate of cell loss during development.
    Brain Res. 1975 Jul 4;92(1):73-87 PMID: 1174947
  16. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.
    Prostaglandins. 1975 Aug;10(2):343-55 PMID: 1178912
  17. Glucocorticosteroid therapy: mechanisms of action and clinical considerations.
    Ann Intern Med. 1976 Mar;84(3):304-15 PMID: 769625
  18. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids.
    Proc Natl Acad Sci U S A. 1976 May;73(5):1730-4 PMID: 1064044
  19. The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards.
    Ann Neurol. 1977 Nov;2(5):364-6 PMID: 617574
  20. Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.
    J Clin Invest. 1981 Jul;68(1):13-20 PMID: 7251857
  21. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
    Lancet. 1983 Jun 18;1(8338):1356-8 PMID: 6134136
  22. Relative immunosuppressive potency of various corticosteroids measured in vitro.
    Eur J Clin Pharmacol. 1983;25(4):459-62 PMID: 6653640
  23. Effect of steroids on immunologic function.
    Prog Clin Biol Res. 1984;161:325-35 PMID: 6483893
  24. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia.
    Pediatrics. 1985 Jan;75(1):106-11 PMID: 3880879
  25. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation.
    Pediatrics. 1985 Mar;75(3):569-74 PMID: 3843297
  26. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up.
    Dev Pharmacol Ther. 1987;10(1):1-11 PMID: 3582071
  27. Dexamethasone in bronchopulmonary dysplasia.
    Arch Dis Child. 1988 Feb;63(2):221 PMID: 3348677
  28. Alveolar macrophage status in bronchopulmonary dysplasia.
    Pediatr Res. 1988 May;23(5):470-3 PMID: 3387169
  29. Development of intestinal host defense: an increased sensitivity in the adenylate cyclase response to cholera toxin in suckling rats.
    Pediatr Res. 1989 Mar;25(3):225-7 PMID: 2704586
  30. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications.
    Eur J Pediatr. 1989 Jan;148(4):365-7 PMID: 2651132
  31. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
    N Engl J Med. 1989 Jun 8;320(23):1505-10 PMID: 2657423
  32. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.
    J Pediatr. 1989 Dec;115(6):979-83 PMID: 2685220
  33. Pulmonary function tests and fluid balance in neonates with chronic lung disease during dexamethasone treatment.
    Pediatrics. 1989 Dec;84(6):1072-6 PMID: 2587137
Article Info
Journal
Archives of disease in childhood
Abbr.
Arch Dis Child
ISSN
1468-2044
DOI
10.1136/adc.68.3_spec_no.330
Published
1993-03-00
Pages
330-6
Language
English
Region
England
NLM ID
0372434
PMCID
PMC1590377
Subset
IM
Corrections
CommentIn
PMID: 8215580
External Links
PubMed source DOI: 10.1136/adc.68.3_spec_no.330 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2